{"id":"W2908296452","doi":"10.1200/jco.2018.36.4_suppl.tps876","title":"NRG-GI002: A phase II clinical trial platform for sensitization testing using total neoadjuvant therapy (TNT) in rectal cancer.","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Colorectal cancer; Total mesorectal excision; Capecitabine; Neoadjuvant therapy; Clinical endpoint; FOLFOX; Internal medicine; Oncology; Chemoradiotherapy; Population; Cancer; Phases of clinical research; Surgery; Randomized controlled trial; Oxaliplatin; Clinical trial; Breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00426259,0.001498268,0.0009893653,0.0005939351,0.0003213719,0.0009871522,0.001189237,0.001526437,0.007852853],"category_scores_gemma":[0.002008297,0.0005142669,0.00106063,0.0005983131,0.001030363,0.0006876532,0.0008114766,0.002537951,0.00151714],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008674576,"about_ca_system_score_gemma":0.003380585,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007682512,"about_ca_topic_score_gemma":0.002671792,"domain_scores_codex":[0.9990138,0.0006340867,0.00003060632,0.00009981851,0.0001078456,0.0001137962],"domain_scores_gemma":[0.998985,0.0001595419,0.0002826129,0.0001222715,0.00006574986,0.0003848223],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.619698,0.07553696,0.007144426,0.00209606,0.001113993,0.0003185996,0.0003506433,0.005790256,0.07660113,0.001975376,0.02330105,0.1860735],"study_design_scores_gemma":[0.5945381,0.3828526,0.006110224,0.00009471107,0.0002767617,0.0002819986,0.00004854227,0.002023321,0.004209111,0.0006570917,0.008869267,0.00003822654],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"protocol","genre_scores_codex":[0.9251938,0.00325096,0.006537297,0.002811895,0.0004559568,0.04216833,0.009028881,0.001087446,0.009465557],"genre_scores_gemma":[0.8572435,0.002994016,0.02999431,0.004415746,0.000363338,0.07922912,0.01314407,0.0002620734,0.01235392],"genre_candidate":"protocol","genre_consensus":null,"teacher_disagreement_score":0.007852853,"threshold_uncertainty_score":0.02627039,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.5393947318110343,"score_gpt":0.6072542489257051,"score_spread":0.06785951711467086,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}